Cargando…
Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse
Methamphetamine (METH) substance abuse disorders have major impact on society, yet no medications have proven successful at preventing METH relapse or cravings. Anti-METH monoclonal antibodies can reduce METH brain concentrations; however, this therapy has limitations, including the need for repeate...
Autores principales: | Hay, Charles E., Gonzalez, Guillermo A., Ewing, Laura E., Reichard, E. Elizabeth, Hambuchen, Michael D., Nanaware-Kharade, Nisha, Alam, Sinthia, Bolden, Chris T., Owens, S. Michael, Margaritis, Paris, Peterson, Eric C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025879/ https://www.ncbi.nlm.nih.gov/pubmed/29958300 http://dx.doi.org/10.1371/journal.pone.0200060 |
Ejemplares similares
-
A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments
por: Nanaware-Kharade, Nisha, et al.
Publicado: (2015) -
Affinity improvement of a therapeutic antibody to methamphetamine and
amphetamine through structure-based antibody engineering
por: Thakkar, Shraddha, et al.
Publicado: (2014) -
Maxillary sinus manifestations of methamphetamine abuse
por: Faucett, Erynne A., et al.
Publicado: (2015) -
Methamphetamine abuse and “meth mouth” in Europe
por: De-Carolis, Carlo, et al.
Publicado: (2015) -
Neural Correlates of Craving in Methamphetamine Abuse
por: Shahmohammadi, Fanak, et al.
Publicado: (2016)